Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
β
of holders' portfolios
13F filers
0
institutions
Market cap
$18.2M
3M shares
52-week range
$3.38 β $11.10
61% from low
Sector
TELEPHONE COMMUNICATIONS (NO RADIOTELEPHONE)
Exchange
NASDAQ
CS
NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
www.nextplat.comNo one on the platform currently holds NXPL.
No tracked institution reports a position in NXPL as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-04-13 | 1-for-10reverse |
No one on the platform has traded NXPL yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$NXPL Iβm bullish on NXPL here. The turnaround is starting to show real results: Q1 revenue reached $9.9M with a record 35% gross margin, while operating expenses continued to decline. Management is targeting positive operating income in the second half of 2026, and the planned pharmacy acquisition adds approximately $5.6M in profitable annual revenue. At this valuation, I believe the risk/reward is attractive if management executes.
View on StockTwits β$NXPL another major takeaway from earnings; βGross margin in the Company's Healthcare Operations segment continued to improve significantly, increasing to approximately 46% in the second quarter of 2026, compared with approximately 39% in the first quarter of 2026 and approximately 20% in the second quarter of 2025.β
View on StockTwits β$NXPL profitable company from now on, great results.
View on StockTwits β$NXPL Thank You David & Team, Amazing Turn Around, Well Done!
View on StockTwits β$NXPL β NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40% https://finance.yahoo.com/healthcare/articles/nextplat-reports-21-sequential-quarterly-120100161.html
View on StockTwits β$NXPL . ππ "During the third quarter of 2026, the Company expects to launch its new nationwide medication fulfillment website, providing consumers across all 50 U.S. states with convenient online access to prescription and over-the-counter healthcare products. The new platform is expected to significantly expand PharmcoRx's reach beyond Florida, establish a scalable national e-commerce sales channel and support future healthcare revenue growth through broader consumer access and new partnership opportunities."
View on StockTwits β$NXPL back out the one time expense of professional fees and πππ. Good things ahead!! Net loss attributable to common stockholders for the quarter ended June 30, 2026 decreased approximately 92% to approximately $0.1 million or ($0.05) per diluted share, compared to a net loss attributable to common stockholders of approximately $1.8 million, or ($0.69) per diluted share for the three months ended June 30, 2025. Excluding the one-time impact of approximately $0.5 million in professional fees, the Company achieved profitability during the second quarter and anticipates generating positive earnings moving forward.
View on StockTwits β$NXPL ππ https://www.stocktitan.net/news/NXPL/next-plat-reports-21-sequential-quarterly-revenue-growth-87-ryqn21fw7sur.html
View on StockTwits β$NXPL During the third quarter of 2026, the Company expects to launch its new nationwide medication fulfillment website, providing consumers across all 50 U.S. states with convenient online access to prescription and over-the-counter healthcare products. The new platform is expected to significantly expand PharmcoRx's reach beyond Florida, establish a scalable national e-commerce sales channel and support future healthcare revenue growth through broader consumer access and new partnership opportunities. https://ir.nextplat.com/news-events/press-releases/detail/178/nextplat-reports-21-sequential-quarterly-revenue-growth-87-reduction-in-quarterly-net-loss-to-144000-and-record-gross-margin-of-approximately-40
View on StockTwits β$NXPL Amazing turn-around and focus by way of David Phipps. Keep it going. Nice Job!
View on StockTwits βRecent $TICKER stream from stocktwits.com β refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $49M | β | $-0.55 | $-0.55β$-0.55 | β | 1 |
| 2027 | $73M | +49.4% | $0.58 | $0.58β$0.58 | 14.0Γ | 1 |
| 2028 | $190M | +160.9% | $0.72 | $0.72β$0.72 | 11.3Γ | 1 |
Forward consensus Β· growth is YoY vs the prior fiscal-year estimate Β· Fwd P/E at the current price Β· source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| NXPLNextPlat Corp | $8.11 | +18.74% | $22M | β |
| AIFFFirefly Neuroscience, Inc. | $1.16 | +4.50% | $17M | β |
| ANYSphere 3D Corp. | $2.09 | -1.42% | $9M | β |
| CXAICXApp Inc. | $0.18 | +8.18% | $10M | β |
| MNDOMIND C.T.I. Ltd | $1.02 | +0.00% | $21M | β |
| NTCLNetClass Technology Inc | $2.97 | +12.50% | $1M | β |
| NVNINvni Group Limited Ordinary Shares | $1.12 | +5.66% | $11M | β |
Source: Financial Modeling Prep Β· peers by sector/industry